APA (7th ed.) Citation

Lues, I., Weber, F., Meyer, A., Bühring, U., Hoffmann, T., Kühn-Wache, K., . . . Glund, K. (2015). A phase 1 study to evaluate the safety and pharmacokinetics of PQ912, a glutaminyl cyclase inhibitor, in healthy subjects. Alzheimer's & dementia : translational research & clinical interventions, 1(3), 182-195. https://doi.org/10.1016/j.trci.2015.08.002

Chicago Style (17th ed.) Citation

Lues, Inge, et al. "A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of PQ912, A glutaminyl Cyclase Inhibitor, in Healthy Subjects." Alzheimer's & Dementia : Translational Research & Clinical Interventions 1, no. 3 (2015): 182-195. https://doi.org/10.1016/j.trci.2015.08.002.

MLA (9th ed.) Citation

Lues, Inge, et al. "A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of PQ912, A glutaminyl Cyclase Inhibitor, in Healthy Subjects." Alzheimer's & Dementia : Translational Research & Clinical Interventions, vol. 1, no. 3, 2015, pp. 182-195, https://doi.org/10.1016/j.trci.2015.08.002.